logo
Select company
Select metric
Ticker Information

Ticker

NERV

Company Name

MINERVA NEUROSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MINERVA NEUROSCIENCES INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NERV - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -32.11M$ 11.23M0%
3/31/2025$ -29.15M$ 6.25M0%
12/31/2024$ -25.69M$ 1.44M0%
9/30/2024$ -21.67M$ -3.31M0%
6/30/2024$ -44.49M$ -33.65M0%
3/31/2024$ -36.59M$ -31.6M0%
12/31/2023$ -28.46M$ -30.01M0%
9/30/2023$ -20.05M$ -27.71M0%
6/30/2023$ -12.51M$ -26.79M0%
3/31/2023$ -26.62M$ -29.31M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for MINERVA NEUROSCIENCES INC is calculated as follows: Net Inc. Cmn. [ $ -20.65M ] / Equity [ $ 58.02M ]
(=) ROE [ -35.59% ]

NERV - Return on Equity, Last 5 years

-625.73%

Minimum

Dec 31, 2021

11.65%

Maximum

Mar 31, 2021

-145.04%

Average

-65.95%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.62% with a standard deviation of 22.53%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.62%
median6.52%
std22.53%